Next Generation Cancer Diagnostic Devices Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032
- Report ID: ME_0086459
- Format: Electronic (PDF)
- Publish Type:
- Number of Pages: 250
Market Snapshot
CAGR:8.01
Source: Market Expertz
| Study Period | 2019-2032 |
| Base Year | 2023 |
| Forcast Year | 2023-2032 |
| CAGR | 8.01 |
Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries
Download Sample PdfReport Overview
The global Next Generation Cancer Diagnostic Devices market is valued at million US$ in 2018 and will reach million US$ by the end of 2026, growing at a CAGR of during 2019-2026. The objectives of this study are to define, segment, and project the size of the Next Generation Cancer Diagnostic Devices market based on company, product type, end user and key regions.This report studies the global market size of Next Generation Cancer Diagnostic Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Next Generation Cancer Diagnostic Devices in these regions.
This research report categorizes the global Next Generation Cancer Diagnostic Devices market by top players/brands, region, type and end user. This report also studies the global Next Generation Cancer Diagnostic Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Roche Holding Ltd.（Switzerland)
Abbott Laboratories(US)
Siemens Healthcare(Germany)
Agilent Technologies Inc(Germany)
Illumina Inc.(US)
Becton Dickinson and Co.(US)
QIAGEN N.V.(Germany)
Affymetrix Inc.(US)
Johnson & Johnson(US)
Thermo Fisher Scientific Inc.(US)
GE Healthcare(England)
Life Technologies Corp.(US)
Luminex Corp.(US)
Cepheid Inc.(US)
Allegro Diagnostics Corp.(Brazil)
Market size by Product
Next Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
Protein Microarrays
DNA Microarrays
Market size by End User
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Next Generation Cancer Diagnostic Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2026.
To understand the structure of Next Generation Cancer Diagnostic Devices market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Next Generation Cancer Diagnostic Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Next Generation Cancer Diagnostic Devices submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Next Generation Cancer Diagnostic Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Next Generation Cancer Diagnostic Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Next Generation Cancer Diagnostic Devices Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Product
1.4.2 Next Generation Sequencing
1.4.3 qPCR & Multiplexing
1.4.4 Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
1.4.5 Protein Microarrays
1.4.6 DNA Microarrays
1.5 Market by End User
1.5.1 Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by End User
1.5.2 Biomarker Development
1.5.3 CTC Analysis
1.5.4 Proteomic Analysis
1.5.5 Epigenetic Analysis
1.5.6 Genetic Analysis
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Next Generation Cancer Diagnostic Devices Market Size
2.1.1 Global Next Generation Cancer Diagnostic Devices Revenue 2014-2025
2.1.2 Global Next Generation Cancer Diagnostic Devices Sales 2014-2025
2.2 Next Generation Cancer Diagnostic Devices Growth Rate by Regions
2.2.1 Global Next Generation Cancer Diagnostic Devices Sales by Regions
2.2.2 Global Next Generation Cancer Diagnostic Devices Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Next Generation Cancer Diagnostic Devices Sales by Manufacturers
3.1.1 Next Generation Cancer Diagnostic Devices Sales by Manufacturers
3.1.2 Next Generation Cancer Diagnostic Devices Sales Market Share by Manufacturers
3.1.3 Global Next Generation Cancer Diagnostic Devices Market Concentration Ratio (CR5 and HHI)
3.2 Next Generation Cancer Diagnostic Devices Revenue by Manufacturers
3.2.1 Next Generation Cancer Diagnostic Devices Revenue by Manufacturers (2014-2019)
3.2.2 Next Generation Cancer Diagnostic Devices Revenue Share by Manufacturers (2014-2019)
3.3 Next Generation Cancer Diagnostic Devices Price by Manufacturers
3.4 Next Generation Cancer Diagnostic Devices Manufacturing Base Distribution, Product Types
3.4.1 Next Generation Cancer Diagnostic Devices Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Next Generation Cancer Diagnostic Devices Product Type
3.4.3 Date of International Manufacturers Enter into Next Generation Cancer Diagnostic Devices Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Next Generation Cancer Diagnostic Devices Sales by Product
4.2 Global Next Generation Cancer Diagnostic Devices Revenue by Product
4.3 Next Generation Cancer Diagnostic Devices Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Next Generation Cancer Diagnostic Devices Breakdown Data by End User
6 North America
6.1 North America Next Generation Cancer Diagnostic Devices by Countries
6.1.1 North America Next Generation Cancer Diagnostic Devices Sales by Countries
6.1.2 North America Next Generation Cancer Diagnostic Devices Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Next Generation Cancer Diagnostic Devices by Product
6.3 North America Next Generation Cancer Diagnostic Devices by End User
7 Europe
7.1 Europe Next Generation Cancer Diagnostic Devices by Countries
7.1.1 Europe Next Generation Cancer Diagnostic Devices Sales by Countries
7.1.2 Europe Next Generation Cancer Diagnostic Devices Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Next Generation Cancer Diagnostic Devices by Product
7.3 Europe Next Generation Cancer Diagnostic Devices by End User
8 Asia Pacific
8.1 Asia Pacific Next Generation Cancer Diagnostic Devices by Countries
8.1.1 Asia Pacific Next Generation Cancer Diagnostic Devices Sales by Countries
8.1.2 Asia Pacific Next Generation Cancer Diagnostic Devices Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Next Generation Cancer Diagnostic Devices by Product
8.3 Asia Pacific Next Generation Cancer Diagnostic Devices by End User
9 Central & South America
9.1 Central & South America Next Generation Cancer Diagnostic Devices by Countries
9.1.1 Central & South America Next Generation Cancer Diagnostic Devices Sales by Countries
9.1.2 Central & South America Next Generation Cancer Diagnostic Devices Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Next Generation Cancer Diagnostic Devices by Product
9.3 Central & South America Next Generation Cancer Diagnostic Devices by End User
10 Middle East and Africa
10.1 Middle East and Africa Next Generation Cancer Diagnostic Devices by Countries
10.1.1 Middle East and Africa Next Generation Cancer Diagnostic Devices Sales by Countries
10.1.2 Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Next Generation Cancer Diagnostic Devices by Product
10.3 Middle East and Africa Next Generation Cancer Diagnostic Devices by End User
11 Company Profiles
11.1 Roche Holding Ltd.（Switzerland)
11.1.1 Roche Holding Ltd.（Switzerland) Company Details
11.1.2 Company Business Overview
11.1.3 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Products Offered
11.1.5 Roche Holding Ltd.（Switzerland) Recent Development
11.2 Abbott Laboratories(US)
11.2.1 Abbott Laboratories(US) Company Details
11.2.2 Company Business Overview
11.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Products Offered
11.2.5 Abbott Laboratories(US) Recent Development
11.3 Siemens Healthcare(Germany)
11.3.1 Siemens Healthcare(Germany) Company Details
11.3.2 Company Business Overview
11.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Products Offered
11.3.5 Siemens Healthcare(Germany) Recent Development
11.4 Agilent Technologies Inc(Germany)
11.4.1 Agilent Technologies Inc(Germany) Company Details
11.4.2 Company Business Overview
11.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Products Offered
11.4.5 Agilent Technologies Inc(Germany) Recent Development
11.5 Illumina Inc.(US)
11.5.1 Illumina Inc.(US) Company Details
11.5.2 Company Business Overview
11.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
11.5.5 Illumina Inc.(US) Recent Development
11.6 Becton Dickinson and Co.(US)
11.6.1 Becton Dickinson and Co.(US) Company Details
11.6.2 Company Business Overview
11.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Products Offered
11.6.5 Becton Dickinson and Co.(US) Recent Development
11.7 QIAGEN N.V.(Germany)
11.7.1 QIAGEN N.V.(Germany) Company Details
11.7.2 Company Business Overview
11.7.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.7.4 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Products Offered
11.7.5 QIAGEN N.V.(Germany) Recent Development
11.8 Affymetrix Inc.(US)
11.8.1 Affymetrix Inc.(US) Company Details
11.8.2 Company Business Overview
11.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
11.8.5 Affymetrix Inc.(US) Recent Development
11.9 Johnson & Johnson(US)
11.9.1 Johnson & Johnson(US) Company Details
11.9.2 Company Business Overview
11.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Products Offered
11.9.5 Johnson & Johnson(US) Recent Development
11.10 Thermo Fisher Scientific Inc.(US)
11.10.1 Thermo Fisher Scientific Inc.(US) Company Details
11.10.2 Company Business Overview
11.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
11.10.5 Thermo Fisher Scientific Inc.(US) Recent Development
11.11 GE Healthcare(England)
11.12 Life Technologies Corp.(US)
11.13 Luminex Corp.(US)
11.14 Cepheid Inc.(US)
11.15 Allegro Diagnostics Corp.(Brazil)
12 Future Forecast
12.1 Next Generation Cancer Diagnostic Devices Market Forecast by Regions
12.1.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Regions 2019-2025
12.1.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Regions 2019-2025
12.2 Next Generation Cancer Diagnostic Devices Market Forecast by Product
12.2.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Product 2019-2025
12.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Product 2019-2025
12.3 Next Generation Cancer Diagnostic Devices Market Forecast by End User
12.4 North America Next Generation Cancer Diagnostic Devices Forecast
12.5 Europe Next Generation Cancer Diagnostic Devices Forecast
12.6 Asia Pacific Next Generation Cancer Diagnostic Devices Forecast
12.7 Central & South America Next Generation Cancer Diagnostic Devices Forecast
12.8 Middle East and Africa Next Generation Cancer Diagnostic Devices Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Next Generation Cancer Diagnostic Devices Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Next Generation Cancer Diagnostic Devices Product Picture
Table Next Generation Cancer Diagnostic Devices Market Segments
Table Key Manufacturers Next Generation Cancer Diagnostic Devices Covered
Table Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Product 2019-2025 (K Pcs) & (Million US$)
Figure Global Next Generation Cancer Diagnostic Devices Sales Market Share by Product 2014-2025
Figure Next Generation Sequencing Product Picture
Table Major Manufacturers of Next Generation Sequencing
Figure qPCR & Multiplexing Product Picture
Table Major Manufacturers of qPCR & Multiplexing
Figure Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) Product Picture
Table Major Manufacturers of Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
Figure Protein Microarrays Product Picture
Table Major Manufacturers of Protein Microarrays
Figure DNA Microarrays Product Picture
Table Major Manufacturers of DNA Microarrays
Table Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by End User 2019-2025 (K Pcs)
Figure Biomarker Development
Figure CTC Analysis
Figure Proteomic Analysis
Figure Epigenetic Analysis
Figure Genetic Analysis
Figure Next Generation Cancer Diagnostic Devices Report Years Considered
Figure Global Next Generation Cancer Diagnostic Devices Market Size 2014-2025 (Million US$)
Figure Global Next Generation Cancer Diagnostic Devices Sales 2014-2025 (K Pcs)
Table Global Next Generation Cancer Diagnostic Devices Market Size by Regions 2014-2019 (K Pcs) & (Million US$)
Table Global Next Generation Cancer Diagnostic Devices Sales by Regions 2014-2019 (K Pcs)
Table Global Next Generation Cancer Diagnostic Devices Sales Market Share by Regions 2014-2019
Figure Global Next Generation Cancer Diagnostic Devices Sales Market Share by Regions 2014-2019
Figure 2018 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Regions
Table Global Next Generation Cancer Diagnostic Devices Revenue by Regions 2014-2019 (Million US$)
Table Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Regions 2014-2019
Figure Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Regions 2014-2019
Figure 2018 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Regions
Table Global Next Generation Cancer Diagnostic Devices Sales by Manufacturers (2014-2019) (K Pcs)
Table Global Next Generation Cancer Diagnostic Devices Sales Share by Manufacturers (2014-2019)
Figure Global Next Generation Cancer Diagnostic Devices Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Next Generation Cancer Diagnostic Devices Revenue by Manufacturers (2014-2019) (Million USD)
Table Next Generation Cancer Diagnostic Devices Revenue Share by Manufacturers (2014-2019)
Figure Next Generation Cancer Diagnostic Devices Value Share by Manufacturers in 2018
Table Key Manufacturers Next Generation Cancer Diagnostic Devices Price (2014-2019) (USD/Pcs)
Table Next Generation Cancer Diagnostic Devices Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Next Generation Cancer Diagnostic Devices Product Type
Table Date of International Manufacturers Enter into Next Generation Cancer Diagnostic Devices Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Next Generation Cancer Diagnostic Devices Sales by Product (2014-2019) (K Pcs)
Table Global Next Generation Cancer Diagnostic Devices Sales Share by Product (2014-2019)
Figure Global Next Generation Cancer Diagnostic Devices Sales Market Share by Product (2014-2019)
Figure Global Next Generation Cancer Diagnostic Devices Sales Market Share by Product in 2018
Table Global Next Generation Cancer Diagnostic Devices Revenue by Product (2014-2019) (Million US$)
Table Global Next Generation Cancer Diagnostic Devices Revenue Share by Product (2014-2019)
Figure Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Product (2014-2019)
Figure Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Product in 2018
Table Next Generation Cancer Diagnostic Devices Price by Product 2014-2019 (USD/Pcs)
Table Global Next Generation Cancer Diagnostic Devices Sales by End User (2014-2019) (K Pcs)
Table Global Next Generation Cancer Diagnostic Devices Sales Share by End User (2014-2019)
Figure Global Sales Next Generation Cancer Diagnostic Devices Market Share by End User (2014-2019)
Figure Global Sales Next Generation Cancer Diagnostic Devices Market Share by End User in 2018
Figure North America Next Generation Cancer Diagnostic Devices Sales Growth Rate 2014-2019 (K Pcs)
Figure North America Next Generation Cancer Diagnostic Devices Revenue Growth Rate 2014-2019 (Million US$)
Table North America Next Generation Cancer Diagnostic Devices Sales by Countries (2014-2019) (K Pcs)
Table North America Next Generation Cancer Diagnostic Devices Sales Market Share by Countries (2014-2019)
Figure 2018 North America Next Generation Cancer Diagnostic Devices Sales Market Share by Countries
Table North America Next Generation Cancer Diagnostic Devices Revenue by Countries (2014-2019) (Million US$)
Table North America Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries
Figure United States Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure United States Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (K Pcs)
Figure Canada Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Canada Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Mexico Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Table North America Next Generation Cancer Diagnostic Devices Sales by Product (2014-2019) (K Pcs)
Table North America Next Generation Cancer Diagnostic Devices Sales Market Share by Product (2014-2019)
Figure 2018 North America Next Generation Cancer Diagnostic Devices Market Share by Product
Table North America Next Generation Cancer Diagnostic Devices Sales by End User (2014-2019) (K Pcs)
Table North America Next Generation Cancer Diagnostic Devices Sales Market Share by End User (2014-2019)
Figure 2018 North America Next Generation Cancer Diagnostic Devices Market Share by End User
Figure Europe Next Generation Cancer Diagnostic Devices Sales Growth Rate 2014-2019 (K Pcs)
Figure Europe Next Generation Cancer Diagnostic Devices Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Next Generation Cancer Diagnostic Devices Sales by Countries (2014-2019) (K Pcs)
Table Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Countries
Table Europe Next Generation Cancer Diagnostic Devices Revenue by Countries (2014-2019) (Million US$)
Table Europe Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries
Figure Germany Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Germany Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure France Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure France Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure UK Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Italy Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Russia Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Next Generation Cancer Diagnostic Devices Sales by Product (2014-2019) (K Pcs)
Table Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Product (2014-2019)
Figure 2018 Europe Next Generation Cancer Diagnostic Devices Market Share by Product
Table Europe Next Generation Cancer Diagnostic Devices Sales by End User (2014-2019) (K Pcs)
Table Europe Next Generation Cancer Diagnostic Devices Sales Market Share by End User (2014-2019)
Figure 2018 Europe Next Generation Cancer Diagnostic Devices Market Share by End User
Figure Asia Pacific Next Generation Cancer Diagnostic Devices Sales Growth Rate 2014-2019 (K Pcs)
Figure Asia Pacific Next Generation Cancer Diagnostic Devices Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Next Generation Cancer Diagnostic Devices Sales by Countries (2014-2019) (K Pcs)
Table Asia Pacific Next Generation Cancer Diagnostic Devices Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Next Generation Cancer Diagnostic Devices Sales Market Share by Countries
Table Asia Pacific Next Generation Cancer Diagnostic Devices Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries
Figure China Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure China Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Japan Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Korea Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure India Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure India Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Australia Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Indonesia Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Malaysia Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Philippines Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Thailand Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Vietnam Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Singapore Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Next Generation Cancer Diagnostic Devices Sales by Product (2014-2019) (K Pcs)
Table Asia Pacific Next Generation Cancer Diagnostic Devices Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Next Generation Cancer Diagnostic Devices Market Share by Product
Table Asia Pacific Next Generation Cancer Diagnostic Devices Sales by End User (2014-2019) (K Pcs)
Table Asia Pacific Next Generation Cancer Diagnostic Devices Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Next Generation Cancer Diagnostic Devices Market Share by End User
Figure Central & South America Next Generation Cancer Diagnostic Devices Sales Growth Rate 2014-2019 (K Pcs)
Figure Central & South America Next Generation Cancer Diagnostic Devices Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Next Generation Cancer Diagnostic Devices Sales by Countries (2014-2019) (K Pcs)
Table Central & South America Next Generation Cancer Diagnostic Devices Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Next Generation Cancer Diagnostic Devices Sales Market Share by Countries
Table Central & South America Next Generation Cancer Diagnostic Devices Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries
Figure Brazil Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Brazil Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Argentina Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Next Generation Cancer Diagnostic Devices Sales by Product (2014-2019) (K Pcs)
Table Central & South America Next Generation Cancer Diagnostic Devices Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Next Generation Cancer Diagnostic Devices Market Share by Product
Table Central & South America Next Generation Cancer Diagnostic Devices Sales by End User (2014-2019) (K Pcs)
Table Central & South America Next Generation Cancer Diagnostic Devices Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Next Generation Cancer Diagnostic Devices Market Share by End User
Figure Middle East and Africa Next Generation Cancer Diagnostic Devices Sales Growth Rate 2014-2019 (K Pcs)
Figure Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Next Generation Cancer Diagnostic Devices Sales by Countries (2014-2019) (K Pcs)
Table Middle East and Africa Next Generation Cancer Diagnostic Devices Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Next Generation Cancer Diagnostic Devices Sales Market Share by Countries
Table Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries
Figure GCC Countries Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure GCC Countries Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Turkey Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Egypt Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure South Africa Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Next Generation Cancer Diagnostic Devices Sales by Product (2014-2019) (K Pcs)
Table Middle East and Africa Next Generation Cancer Diagnostic Devices Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Next Generation Cancer Diagnostic Devices Market Share by Product
Table Middle East and Africa Next Generation Cancer Diagnostic Devices Sales by End User (2014-2019) (K Pcs)
Table Middle East and Africa Next Generation Cancer Diagnostic Devices Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Next Generation Cancer Diagnostic Devices Market Share by End User
Table Roche Holding Ltd.（Switzerland) Company Details
Table Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Roche Holding Ltd.（Switzerland) Recent Development
Table Abbott Laboratories(US) Company Details
Table Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Abbott Laboratories(US) Recent Development
Table Siemens Healthcare(Germany) Company Details
Table Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Siemens Healthcare(Germany) Recent Development
Table Agilent Technologies Inc(Germany) Company Details
Table Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Agilent Technologies Inc(Germany) Recent Development
Table Illumina Inc.(US) Company Details
Table Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Illumina Inc.(US) Recent Development
Table Becton Dickinson and Co.(US) Company Details
Table Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Becton Dickinson and Co.(US) Recent Development
Table QIAGEN N.V.(Germany) Company Details
Table QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table QIAGEN N.V.(Germany) Recent Development
Table Affymetrix Inc.(US) Company Details
Table Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Affymetrix Inc.(US) Recent Development
Table Johnson & Johnson(US) Company Details
Table Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson & Johnson(US) Recent Development
Table Thermo Fisher Scientific Inc.(US) Company Details
Table Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Thermo Fisher Scientific Inc.(US) Recent Development
Table GE Healthcare(England) Company Details
Table Life Technologies Corp.(US) Company Details
Table Luminex Corp.(US) Company Details
Table Cepheid Inc.(US) Company Details
Table Allegro Diagnostics Corp.(Brazil) Company Details
Table Global Next Generation Cancer Diagnostic Devices Sales Forecast by Regions 2019-2025 (K Pcs)
Table Global Next Generation Cancer Diagnostic Devices Sales Market Share Forecast by Regions 2019-2025
Table Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Next Generation Cancer Diagnostic Devices Revenue Market Share Forecast by Regions 2019-2025
Table Global Next Generation Cancer Diagnostic Devices Sales Forecast by Product 2019-2025 (K Pcs)
Table Global Next Generation Cancer Diagnostic Devices Sales Market Share Forecast by Product 2019-2025
Table Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Next Generation Cancer Diagnostic Devices Revenue Market Share Forecast by Product 2019-2025
Table Global Next Generation Cancer Diagnostic Devices Sales Forecast by End User 2019-2025 (K Pcs)
Table Global Next Generation Cancer Diagnostic Devices Sales Market Share Forecast by End User 2019-2025
Figure North America Next Generation Cancer Diagnostic Devices Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure North America Next Generation Cancer Diagnostic Devices Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Next Generation Cancer Diagnostic Devices Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Europe Next Generation Cancer Diagnostic Devices Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Next Generation Cancer Diagnostic Devices Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Asia Pacific Next Generation Cancer Diagnostic Devices Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Next Generation Cancer Diagnostic Devices Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Central & South America Next Generation Cancer Diagnostic Devices Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Next Generation Cancer Diagnostic Devices Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Next Generation Cancer Diagnostic Devices Value Chain
Table Next Generation Cancer Diagnostic Devices Customers List
Table Next Generation Cancer Diagnostic Devices Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
1 Study Coverage
1.1 Next Generation Cancer Diagnostic Devices Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Product
1.4.2 Next Generation Sequencing
1.4.3 qPCR & Multiplexing
1.4.4 Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
1.4.5 Protein Microarrays
1.4.6 DNA Microarrays
1.5 Market by End User
1.5.1 Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by End User
1.5.2 Biomarker Development
1.5.3 CTC Analysis
1.5.4 Proteomic Analysis
1.5.5 Epigenetic Analysis
1.5.6 Genetic Analysis
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Next Generation Cancer Diagnostic Devices Market Size
2.1.1 Global Next Generation Cancer Diagnostic Devices Revenue 2014-2025
2.1.2 Global Next Generation Cancer Diagnostic Devices Sales 2014-2025
2.2 Next Generation Cancer Diagnostic Devices Growth Rate by Regions
2.2.1 Global Next Generation Cancer Diagnostic Devices Sales by Regions
2.2.2 Global Next Generation Cancer Diagnostic Devices Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Next Generation Cancer Diagnostic Devices Sales by Manufacturers
3.1.1 Next Generation Cancer Diagnostic Devices Sales by Manufacturers
3.1.2 Next Generation Cancer Diagnostic Devices Sales Market Share by Manufacturers
3.1.3 Global Next Generation Cancer Diagnostic Devices Market Concentration Ratio (CR5 and HHI)
3.2 Next Generation Cancer Diagnostic Devices Revenue by Manufacturers
3.2.1 Next Generation Cancer Diagnostic Devices Revenue by Manufacturers (2014-2019)
3.2.2 Next Generation Cancer Diagnostic Devices Revenue Share by Manufacturers (2014-2019)
3.3 Next Generation Cancer Diagnostic Devices Price by Manufacturers
3.4 Next Generation Cancer Diagnostic Devices Manufacturing Base Distribution, Product Types
3.4.1 Next Generation Cancer Diagnostic Devices Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Next Generation Cancer Diagnostic Devices Product Type
3.4.3 Date of International Manufacturers Enter into Next Generation Cancer Diagnostic Devices Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Next Generation Cancer Diagnostic Devices Sales by Product
4.2 Global Next Generation Cancer Diagnostic Devices Revenue by Product
4.3 Next Generation Cancer Diagnostic Devices Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Next Generation Cancer Diagnostic Devices Breakdown Data by End User
6 North America
6.1 North America Next Generation Cancer Diagnostic Devices by Countries
6.1.1 North America Next Generation Cancer Diagnostic Devices Sales by Countries
6.1.2 North America Next Generation Cancer Diagnostic Devices Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Next Generation Cancer Diagnostic Devices by Product
6.3 North America Next Generation Cancer Diagnostic Devices by End User
7 Europe
7.1 Europe Next Generation Cancer Diagnostic Devices by Countries
7.1.1 Europe Next Generation Cancer Diagnostic Devices Sales by Countries
7.1.2 Europe Next Generation Cancer Diagnostic Devices Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Next Generation Cancer Diagnostic Devices by Product
7.3 Europe Next Generation Cancer Diagnostic Devices by End User
8 Asia Pacific
8.1 Asia Pacific Next Generation Cancer Diagnostic Devices by Countries
8.1.1 Asia Pacific Next Generation Cancer Diagnostic Devices Sales by Countries
8.1.2 Asia Pacific Next Generation Cancer Diagnostic Devices Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Next Generation Cancer Diagnostic Devices by Product
8.3 Asia Pacific Next Generation Cancer Diagnostic Devices by End User
9 Central & South America
9.1 Central & South America Next Generation Cancer Diagnostic Devices by Countries
9.1.1 Central & South America Next Generation Cancer Diagnostic Devices Sales by Countries
9.1.2 Central & South America Next Generation Cancer Diagnostic Devices Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Next Generation Cancer Diagnostic Devices by Product
9.3 Central & South America Next Generation Cancer Diagnostic Devices by End User
10 Middle East and Africa
10.1 Middle East and Africa Next Generation Cancer Diagnostic Devices by Countries
10.1.1 Middle East and Africa Next Generation Cancer Diagnostic Devices Sales by Countries
10.1.2 Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Next Generation Cancer Diagnostic Devices by Product
10.3 Middle East and Africa Next Generation Cancer Diagnostic Devices by End User
11 Company Profiles
11.1 Roche Holding Ltd.（Switzerland)
11.1.1 Roche Holding Ltd.（Switzerland) Company Details
11.1.2 Company Business Overview
11.1.3 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Products Offered
11.1.5 Roche Holding Ltd.（Switzerland) Recent Development
11.2 Abbott Laboratories(US)
11.2.1 Abbott Laboratories(US) Company Details
11.2.2 Company Business Overview
11.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Products Offered
11.2.5 Abbott Laboratories(US) Recent Development
11.3 Siemens Healthcare(Germany)
11.3.1 Siemens Healthcare(Germany) Company Details
11.3.2 Company Business Overview
11.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Products Offered
11.3.5 Siemens Healthcare(Germany) Recent Development
11.4 Agilent Technologies Inc(Germany)
11.4.1 Agilent Technologies Inc(Germany) Company Details
11.4.2 Company Business Overview
11.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Products Offered
11.4.5 Agilent Technologies Inc(Germany) Recent Development
11.5 Illumina Inc.(US)
11.5.1 Illumina Inc.(US) Company Details
11.5.2 Company Business Overview
11.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
11.5.5 Illumina Inc.(US) Recent Development
11.6 Becton Dickinson and Co.(US)
11.6.1 Becton Dickinson and Co.(US) Company Details
11.6.2 Company Business Overview
11.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Products Offered
11.6.5 Becton Dickinson and Co.(US) Recent Development
11.7 QIAGEN N.V.(Germany)
11.7.1 QIAGEN N.V.(Germany) Company Details
11.7.2 Company Business Overview
11.7.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.7.4 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Products Offered
11.7.5 QIAGEN N.V.(Germany) Recent Development
11.8 Affymetrix Inc.(US)
11.8.1 Affymetrix Inc.(US) Company Details
11.8.2 Company Business Overview
11.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
11.8.5 Affymetrix Inc.(US) Recent Development
11.9 Johnson & Johnson(US)
11.9.1 Johnson & Johnson(US) Company Details
11.9.2 Company Business Overview
11.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Products Offered
11.9.5 Johnson & Johnson(US) Recent Development
11.10 Thermo Fisher Scientific Inc.(US)
11.10.1 Thermo Fisher Scientific Inc.(US) Company Details
11.10.2 Company Business Overview
11.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
11.10.5 Thermo Fisher Scientific Inc.(US) Recent Development
11.11 GE Healthcare(England)
11.12 Life Technologies Corp.(US)
11.13 Luminex Corp.(US)
11.14 Cepheid Inc.(US)
11.15 Allegro Diagnostics Corp.(Brazil)
12 Future Forecast
12.1 Next Generation Cancer Diagnostic Devices Market Forecast by Regions
12.1.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Regions 2019-2025
12.1.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Regions 2019-2025
12.2 Next Generation Cancer Diagnostic Devices Market Forecast by Product
12.2.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Product 2019-2025
12.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Product 2019-2025
12.3 Next Generation Cancer Diagnostic Devices Market Forecast by End User
12.4 North America Next Generation Cancer Diagnostic Devices Forecast
12.5 Europe Next Generation Cancer Diagnostic Devices Forecast
12.6 Asia Pacific Next Generation Cancer Diagnostic Devices Forecast
12.7 Central & South America Next Generation Cancer Diagnostic Devices Forecast
12.8 Middle East and Africa Next Generation Cancer Diagnostic Devices Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Next Generation Cancer Diagnostic Devices Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Next Generation Cancer Diagnostic Devices Product Picture
Table Next Generation Cancer Diagnostic Devices Market Segments
Table Key Manufacturers Next Generation Cancer Diagnostic Devices Covered
Table Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Product 2019-2025 (K Pcs) & (Million US$)
Figure Global Next Generation Cancer Diagnostic Devices Sales Market Share by Product 2014-2025
Figure Next Generation Sequencing Product Picture
Table Major Manufacturers of Next Generation Sequencing
Figure qPCR & Multiplexing Product Picture
Table Major Manufacturers of qPCR & Multiplexing
Figure Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) Product Picture
Table Major Manufacturers of Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
Figure Protein Microarrays Product Picture
Table Major Manufacturers of Protein Microarrays
Figure DNA Microarrays Product Picture
Table Major Manufacturers of DNA Microarrays
Table Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by End User 2019-2025 (K Pcs)
Figure Biomarker Development
Figure CTC Analysis
Figure Proteomic Analysis
Figure Epigenetic Analysis
Figure Genetic Analysis
Figure Next Generation Cancer Diagnostic Devices Report Years Considered
Figure Global Next Generation Cancer Diagnostic Devices Market Size 2014-2025 (Million US$)
Figure Global Next Generation Cancer Diagnostic Devices Sales 2014-2025 (K Pcs)
Table Global Next Generation Cancer Diagnostic Devices Market Size by Regions 2014-2019 (K Pcs) & (Million US$)
Table Global Next Generation Cancer Diagnostic Devices Sales by Regions 2014-2019 (K Pcs)
Table Global Next Generation Cancer Diagnostic Devices Sales Market Share by Regions 2014-2019
Figure Global Next Generation Cancer Diagnostic Devices Sales Market Share by Regions 2014-2019
Figure 2018 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Regions
Table Global Next Generation Cancer Diagnostic Devices Revenue by Regions 2014-2019 (Million US$)
Table Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Regions 2014-2019
Figure Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Regions 2014-2019
Figure 2018 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Regions
Table Global Next Generation Cancer Diagnostic Devices Sales by Manufacturers (2014-2019) (K Pcs)
Table Global Next Generation Cancer Diagnostic Devices Sales Share by Manufacturers (2014-2019)
Figure Global Next Generation Cancer Diagnostic Devices Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Next Generation Cancer Diagnostic Devices Revenue by Manufacturers (2014-2019) (Million USD)
Table Next Generation Cancer Diagnostic Devices Revenue Share by Manufacturers (2014-2019)
Figure Next Generation Cancer Diagnostic Devices Value Share by Manufacturers in 2018
Table Key Manufacturers Next Generation Cancer Diagnostic Devices Price (2014-2019) (USD/Pcs)
Table Next Generation Cancer Diagnostic Devices Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Next Generation Cancer Diagnostic Devices Product Type
Table Date of International Manufacturers Enter into Next Generation Cancer Diagnostic Devices Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Next Generation Cancer Diagnostic Devices Sales by Product (2014-2019) (K Pcs)
Table Global Next Generation Cancer Diagnostic Devices Sales Share by Product (2014-2019)
Figure Global Next Generation Cancer Diagnostic Devices Sales Market Share by Product (2014-2019)
Figure Global Next Generation Cancer Diagnostic Devices Sales Market Share by Product in 2018
Table Global Next Generation Cancer Diagnostic Devices Revenue by Product (2014-2019) (Million US$)
Table Global Next Generation Cancer Diagnostic Devices Revenue Share by Product (2014-2019)
Figure Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Product (2014-2019)
Figure Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Product in 2018
Table Next Generation Cancer Diagnostic Devices Price by Product 2014-2019 (USD/Pcs)
Table Global Next Generation Cancer Diagnostic Devices Sales by End User (2014-2019) (K Pcs)
Table Global Next Generation Cancer Diagnostic Devices Sales Share by End User (2014-2019)
Figure Global Sales Next Generation Cancer Diagnostic Devices Market Share by End User (2014-2019)
Figure Global Sales Next Generation Cancer Diagnostic Devices Market Share by End User in 2018
Figure North America Next Generation Cancer Diagnostic Devices Sales Growth Rate 2014-2019 (K Pcs)
Figure North America Next Generation Cancer Diagnostic Devices Revenue Growth Rate 2014-2019 (Million US$)
Table North America Next Generation Cancer Diagnostic Devices Sales by Countries (2014-2019) (K Pcs)
Table North America Next Generation Cancer Diagnostic Devices Sales Market Share by Countries (2014-2019)
Figure 2018 North America Next Generation Cancer Diagnostic Devices Sales Market Share by Countries
Table North America Next Generation Cancer Diagnostic Devices Revenue by Countries (2014-2019) (Million US$)
Table North America Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries
Figure United States Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure United States Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (K Pcs)
Figure Canada Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Canada Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Mexico Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Table North America Next Generation Cancer Diagnostic Devices Sales by Product (2014-2019) (K Pcs)
Table North America Next Generation Cancer Diagnostic Devices Sales Market Share by Product (2014-2019)
Figure 2018 North America Next Generation Cancer Diagnostic Devices Market Share by Product
Table North America Next Generation Cancer Diagnostic Devices Sales by End User (2014-2019) (K Pcs)
Table North America Next Generation Cancer Diagnostic Devices Sales Market Share by End User (2014-2019)
Figure 2018 North America Next Generation Cancer Diagnostic Devices Market Share by End User
Figure Europe Next Generation Cancer Diagnostic Devices Sales Growth Rate 2014-2019 (K Pcs)
Figure Europe Next Generation Cancer Diagnostic Devices Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Next Generation Cancer Diagnostic Devices Sales by Countries (2014-2019) (K Pcs)
Table Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Countries
Table Europe Next Generation Cancer Diagnostic Devices Revenue by Countries (2014-2019) (Million US$)
Table Europe Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries
Figure Germany Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Germany Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure France Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure France Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure UK Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Italy Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Russia Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Next Generation Cancer Diagnostic Devices Sales by Product (2014-2019) (K Pcs)
Table Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Product (2014-2019)
Figure 2018 Europe Next Generation Cancer Diagnostic Devices Market Share by Product
Table Europe Next Generation Cancer Diagnostic Devices Sales by End User (2014-2019) (K Pcs)
Table Europe Next Generation Cancer Diagnostic Devices Sales Market Share by End User (2014-2019)
Figure 2018 Europe Next Generation Cancer Diagnostic Devices Market Share by End User
Figure Asia Pacific Next Generation Cancer Diagnostic Devices Sales Growth Rate 2014-2019 (K Pcs)
Figure Asia Pacific Next Generation Cancer Diagnostic Devices Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Next Generation Cancer Diagnostic Devices Sales by Countries (2014-2019) (K Pcs)
Table Asia Pacific Next Generation Cancer Diagnostic Devices Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Next Generation Cancer Diagnostic Devices Sales Market Share by Countries
Table Asia Pacific Next Generation Cancer Diagnostic Devices Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries
Figure China Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure China Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Japan Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Korea Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure India Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure India Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Australia Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Indonesia Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Malaysia Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Philippines Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Thailand Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Vietnam Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Singapore Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Next Generation Cancer Diagnostic Devices Sales by Product (2014-2019) (K Pcs)
Table Asia Pacific Next Generation Cancer Diagnostic Devices Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Next Generation Cancer Diagnostic Devices Market Share by Product
Table Asia Pacific Next Generation Cancer Diagnostic Devices Sales by End User (2014-2019) (K Pcs)
Table Asia Pacific Next Generation Cancer Diagnostic Devices Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Next Generation Cancer Diagnostic Devices Market Share by End User
Figure Central & South America Next Generation Cancer Diagnostic Devices Sales Growth Rate 2014-2019 (K Pcs)
Figure Central & South America Next Generation Cancer Diagnostic Devices Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Next Generation Cancer Diagnostic Devices Sales by Countries (2014-2019) (K Pcs)
Table Central & South America Next Generation Cancer Diagnostic Devices Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Next Generation Cancer Diagnostic Devices Sales Market Share by Countries
Table Central & South America Next Generation Cancer Diagnostic Devices Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries
Figure Brazil Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Brazil Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Argentina Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Next Generation Cancer Diagnostic Devices Sales by Product (2014-2019) (K Pcs)
Table Central & South America Next Generation Cancer Diagnostic Devices Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Next Generation Cancer Diagnostic Devices Market Share by Product
Table Central & South America Next Generation Cancer Diagnostic Devices Sales by End User (2014-2019) (K Pcs)
Table Central & South America Next Generation Cancer Diagnostic Devices Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Next Generation Cancer Diagnostic Devices Market Share by End User
Figure Middle East and Africa Next Generation Cancer Diagnostic Devices Sales Growth Rate 2014-2019 (K Pcs)
Figure Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Next Generation Cancer Diagnostic Devices Sales by Countries (2014-2019) (K Pcs)
Table Middle East and Africa Next Generation Cancer Diagnostic Devices Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Next Generation Cancer Diagnostic Devices Sales Market Share by Countries
Table Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries
Figure GCC Countries Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure GCC Countries Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Turkey Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure Egypt Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Next Generation Cancer Diagnostic Devices Sales Growth Rate (2014-2019) (K Pcs)
Figure South Africa Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Next Generation Cancer Diagnostic Devices Sales by Product (2014-2019) (K Pcs)
Table Middle East and Africa Next Generation Cancer Diagnostic Devices Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Next Generation Cancer Diagnostic Devices Market Share by Product
Table Middle East and Africa Next Generation Cancer Diagnostic Devices Sales by End User (2014-2019) (K Pcs)
Table Middle East and Africa Next Generation Cancer Diagnostic Devices Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Next Generation Cancer Diagnostic Devices Market Share by End User
Table Roche Holding Ltd.（Switzerland) Company Details
Table Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Roche Holding Ltd.（Switzerland) Recent Development
Table Abbott Laboratories(US) Company Details
Table Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Abbott Laboratories(US) Recent Development
Table Siemens Healthcare(Germany) Company Details
Table Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Siemens Healthcare(Germany) Recent Development
Table Agilent Technologies Inc(Germany) Company Details
Table Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Agilent Technologies Inc(Germany) Recent Development
Table Illumina Inc.(US) Company Details
Table Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Illumina Inc.(US) Recent Development
Table Becton Dickinson and Co.(US) Company Details
Table Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Becton Dickinson and Co.(US) Recent Development
Table QIAGEN N.V.(Germany) Company Details
Table QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table QIAGEN N.V.(Germany) Recent Development
Table Affymetrix Inc.(US) Company Details
Table Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Affymetrix Inc.(US) Recent Development
Table Johnson & Johnson(US) Company Details
Table Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson & Johnson(US) Recent Development
Table Thermo Fisher Scientific Inc.(US) Company Details
Table Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Thermo Fisher Scientific Inc.(US) Recent Development
Table GE Healthcare(England) Company Details
Table Life Technologies Corp.(US) Company Details
Table Luminex Corp.(US) Company Details
Table Cepheid Inc.(US) Company Details
Table Allegro Diagnostics Corp.(Brazil) Company Details
Table Global Next Generation Cancer Diagnostic Devices Sales Forecast by Regions 2019-2025 (K Pcs)
Table Global Next Generation Cancer Diagnostic Devices Sales Market Share Forecast by Regions 2019-2025
Table Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Next Generation Cancer Diagnostic Devices Revenue Market Share Forecast by Regions 2019-2025
Table Global Next Generation Cancer Diagnostic Devices Sales Forecast by Product 2019-2025 (K Pcs)
Table Global Next Generation Cancer Diagnostic Devices Sales Market Share Forecast by Product 2019-2025
Table Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Next Generation Cancer Diagnostic Devices Revenue Market Share Forecast by Product 2019-2025
Table Global Next Generation Cancer Diagnostic Devices Sales Forecast by End User 2019-2025 (K Pcs)
Table Global Next Generation Cancer Diagnostic Devices Sales Market Share Forecast by End User 2019-2025
Figure North America Next Generation Cancer Diagnostic Devices Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure North America Next Generation Cancer Diagnostic Devices Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Next Generation Cancer Diagnostic Devices Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Europe Next Generation Cancer Diagnostic Devices Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Next Generation Cancer Diagnostic Devices Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Asia Pacific Next Generation Cancer Diagnostic Devices Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Next Generation Cancer Diagnostic Devices Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Central & South America Next Generation Cancer Diagnostic Devices Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Next Generation Cancer Diagnostic Devices Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Next Generation Cancer Diagnostic Devices Value Chain
Table Next Generation Cancer Diagnostic Devices Customers List
Table Next Generation Cancer Diagnostic Devices Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now let’s take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.
You can also purchase parts of this report. Do you want to check out a section wise price list?
Personalized Business Report Tailored to Your Requirements
- Our expert analysts collaborate directly with you to comprehend your specific needs.
- Get data on regions, segments, competitors, and vendors of your choice.
- Information is presented in alignment with your exact preferences and formatting.
Free Sample Report
"Find new revenue generation opportunities"